[Musica] Esiste la vita nello spazio. Sono secoli che ci poniamo questa domanda e ancora oggi non siamo riusciti a dare una risposta esaustiva. Cercare la vita nello spazio significa mettere insieme conoscenze che vengono dalla scienza, dalla tecnologia, dalla filosofia e perché no, farci anche ispirare dalla fantascienza.Oggi conosciamo più di 5.000% pianeti extrasolari e i grandi telescopi, le missioni spaziali ci stanno mostrando ambienti sempre più complessi. Quindi ipotizzare che esistano mondi abitabi ...

Raúl Tovar toma el escenario de las TEDx Anáhuac University organizadas por Vértice, el Programa de Excelencia Anáhuac y nos habla sobre simulaciones espaciales para entrenar astronautas, proyectos mexicanos innovadores y cómo empresas como SpaceX hacen posible la exploración de Marte. También subraya la importancia de cuidar la Tierra, nuestro único hogar con vida. Científico, Piloto y Empresario. Piloto mexicano, científico, astronauta analógico y orador de TEDx con más de 200 horas de vuelo. Ganador del ...

Core Viewpoint - Abaxx Technologies Inc. has launched its physically-deliverable Gold Singapore Futures, which began active trading on June 12, 2025, providing a new tool for price discovery and hedging in the Asian market [1][3]. Company Overview - Abaxx Technologies is a financial software and market infrastructure company, and the majority shareholder of Abaxx Singapore Pte Ltd., which owns the Abaxx Commodity Exchange and Clearinghouse [1][7]. - The company aims to create Smarter Markets by developing better tools and technology to address significant societal challenges, including the energy transition [6]. Product Details - The Gold Singapore Futures contract is a USD-denominated, kilobar-sized product designed for the regional physical bullion trade, deliverable into approved vaults in Singapore [2][3]. - This contract is tailored for refiners, industrial consumers, banks, and physical traders in Asia, addressing the growing demand for regional price transparency [3][5]. Market Participation - The initial trading sessions of the Gold Singapore Futures saw participation from eight market makers, including firms from Singapore, Hong Kong, London, and Thailand, with expectations for more participants in the future [4]. - KGI Securities Singapore expressed enthusiasm for the new offering, highlighting its relevance to the Asian market and commitment to providing comprehensive solutions in commodities [5]. Trading Specifications - The Abaxx Gold Singapore Futures contract is available for trading 14 hours per day, Monday through Friday, facilitating access for market participants [5].

Revenue of $3.4 Million for Q1 2025, Representing 213% Growth from Q1 2024 Gross Profit of $2.8 Million for Q1 2025, Representing 297% Growth from Q1 2024; Gross Margin Expanded to 82.1% in Q1 2025 from 64.7% in Q1 2024 Q1 2025 Net Loss Improved to ($3.6) Million from ($7.9) Million in Q4 2024, Positioning the Company to Cash Break-Even Operations in FY2025 Management to Host First Quarter 2025 Results Conference Call Today, Thursday, May 15, 2025 at 5:45 p.m. Eastern Time SEATTLE, May 15, 2025 (GLOBE NEWSW ...

BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Springbig (OTCQB: SBIG), a leading provider of marketing automation software and customer loyalty solutions, is excited to announce the addition of three seasoned executives to its leadership team. These strategic hires reflect the company’s commitment to continued growth, innovation, and operational excellence as it scales its SaaS platform and services across North America. Springbig also recently announced that Jaret Christopher has joined the company as ...

今天分享的是：Focussend：2025年全渠道自动化实战手册 报告共计：48页 《2025年全渠道自动化实战手册》由Focussend修订，旨在为市场部门提供营销增长的确定性，助力企业在数字化营销领域发 展。 1. 营销自动化概述：营销自动化（MA）是集多种营销功能于一体的数字化营销系统，能整合营销资源、优化运营流程、提升效 率并促进营销增长。它与CRM、SCRM不同，侧重于全链路运营、用户交互和培育等。其发展历经多个阶段，未来将与AIGC融 合，实现跨部门协同，满足企业私域运营需求，并获得更高决策层的支持。 2. 营销自动化的价值与战略意义：MA可实现营销的战略性增长，赋能精细化存量运营。它能放大和加速营销策略，通过多触点 获取数据，实现智能化、自动化运营。同时，MA提升营销竞争能力，推动从粗放到精准营销的转变。此外，还能推动组织效率 提升和进化，促进市场部向"客户增长中心"转型，加强市场与销售的协作。 3. 实现营销战略性增长的方式：企业需制定GTM策略，MA与该策略在客户洞察、效率和营销增长等方面契合。在全渠道引流 获客上，要建立获客渠道分析模型和矩阵，拓展线上线下获客渠道。重视客户培育，构建客户画 ...

Financial Data and Key Metrics Changes - For Q2 of fiscal 2025, total revenue was $124.3 million, a 4.4% increase from $119 million in Q2 of fiscal 2024, primarily driven by an increase in RMS segment revenue [8][25] - Adjusted EBITDA for Q2 was $8 million, or 6.4% of total revenue, compared to $3.1 million, or 2.6% of total revenue in the same quarter last year [27][28] - Consolidated net loss attributable to common shareholders was $14.9 million, or a loss of $0.44 per diluted share, compared to a loss of $48.1 million, or $1.86 per diluted share in Q2 of fiscal 2024 [27] Business Line Data and Key Metrics Changes - RMS segment revenue increased by $6.6 million, or 9.1%, compared to Q2 of fiscal 2024, mainly due to higher NHP volumes sold [25][26] - DSA revenue decreased to $45.3 million from $46.6 million in Q2 of fiscal 2024, primarily due to a decline in general toxicology services revenue [26] - DSA net new orders were $44.5 million, a 27% increase over Q2 of fiscal 2024, with a book to bill ratio of 1.01:1 [26][28] Market Data and Key Metrics Changes - The company noted geopolitical and macroeconomic risks affecting the industry, but expects continued year-over-year revenue and adjusted EBITDA growth for the next two quarters [9][23] - The company has not seen material changes in demand due to current tariffs, although there is some cost inflation linked to tariffs [22][23] Company Strategy and Development Direction - The company is focused on client satisfaction, integration of scientific services, and site optimization plans to improve operational efficiency and margins [7][10] - A revised RMS site optimization plan is expected to yield annual cost savings of $6 million to $7 million, with completion anticipated by March 2026 [11][12] - The company is adapting to FDA announcements regarding drug development and animal testing, positioning itself to leverage new methodologies [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the level of quoting and awards in the DSA segment, expecting improvements in margins starting in Q3 of fiscal 2025 [49][86] - The company is monitoring NIH funding impacts but has not seen significant changes in business yet [52][54] - Management remains confident in the company's ability to navigate geopolitical and macroeconomic uncertainties while creating value for clients and shareholders [23][24] Other Important Information - The company plans to hold an Investor Day on May 29 to further discuss its strategic plan and focus on client excellence [87] - The company has made significant investments in acquisitions and site optimizations to prepare for future growth [7][10] Q&A Session Summary Question: Changes in marketing strategies post-FDA announcement - Management has integrated new services into their discovery sales process and is seeing some growth, though not as rapid as expected [35][36] Question: Focus areas in the revised RMS optimization plan - The revised plan aims to improve efficiencies and reduce costs, with a focus on maximizing existing resources rather than expanding capacity [40][41] Question: Current demand trends and quoting activity - Management reported a positive start to the current quarter, with strong quoting and closing activity [46][49] Question: Impact of NIH funding on customer mix - There has been no dramatic impact from NIH funding yet, with some customers increasing orders while others have reduced them [52][54] Question: DSA margin improvement timeline - Management expects to see benefits from identified margin improvement areas sooner rather than later, with some improvements already noted [66][68]